|
Phillip pregunto:
What company are you calling from? http://www.thedenvereye.com/tomorrow/ gentleman wicked accutane 10 years later youth Despite only treating a few thousand patients worldwide, sales of Alexion´s rare blood disease drug Solaris are forecast by analysts to reach $1.5 billion this year. Citi analysts forecast peak sales for Alexion of $6 billion in 2025. |
|
|
|
